Intellectual Property - April 15, 2023
Ultimovacs receives Intention to Grant Notice on European Patent
Ultimovacs has received a Notice of Intention to Grant from the European Patent Office (EPO) concerning its European Patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer. Subject to grant formalities including translations and fee disbursement, the European patent will issue with a patent term to June 2037. When granted, the European […]
Intellectual Property - March 28, 2023
SynAct strengthens its patent portfolio
SynAct Pharma’s recently acquired affiliate TXP Pharma was granted a patent in Canada related to “Alpha- and gamma-MSH analogues”. In addition, TXP’s patent application in another patent family relating to ”Exendin-4-analogues” has entered national phase in significant countries and regions worldwide. Read more: SynAct acquires TXP Pharma and carries out a directed share issue TXP […]
Intellectual Property - March 2, 2023
Diamyd Medical receives patent protection in the US and Japan
The US Patent and Trademark Office (USPTO) and the Japanese Patent Office have informed Diamyd Medical that they will grant the patent for the company’s oral formulation of the GABA-based study drug Remygen. Remygen is currently in Phase 2 development through the ReGenerate-1 trial in individuals with long-term Type 1 Diabetes. Results are expected later […]
Biotech Business - January 23, 2023
Modus Therapeutics submits patent application
Modus Therapeutics has submitted a patent application claiming the use of sevuparin, its lead asset, for the treatment of kidney disease. The patent application is based on novel preclinical work that was undertaken in an established kidney disease animal model during an academic collaboration project. A granted patent would provide patent protection until at least […]
Intellectual Property - September 9, 2022
Salipro Biotech granted patent in the US and China
Salipro Biotech has announced that its patent entitled “Saposin lipoprotein particles and libraries from crude membranes” has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company’s novel method of direct extraction of membrane proteins (DirectMX) from cells or crude membranes to […]
Intellectual Property - August 30, 2022
NextCell granted patent protection in Japan
NextCell Pharma has announced that the Japan Patent Office (JPO) has issued a notice of allowance relating to the patent entitled “Allogeneic Composition”. The patent describes the method of manufacturing the drug candidate ProTrans, where the selection algorithm is key for selecting optimal cells and donors. “Japan is leading the cell therapy and stem cells […]
